✦ LIBER ✦

Reply: Why R-CHOP for first line treatment of chronic lymphocytic leukemia?

Book ID: 108702832
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 32 KB
Volume: 29
Category: Article
ISSN: 1751-5521
DOI: 10.1111/j.1365-2257.2006.00878_2.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Why R-CHOP for first line treatment of c

Why R-CHOP for first line treatment of chronic lymphocytic leukemia?

✍ L. Smolej 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Chronic Lymphocytic Leukemia (CLL): Firs

Chronic Lymphocytic Leukemia (CLL): First-Line Treatment

✍ Hallek, M. 📂 Article 📅 2005 🏛 American Society of Hematology 🌐 English ⚖ 71 KB

Making Advances in First-Line Chronic Ly

Making Advances in First-Line Chronic Lymphocytic Leukemia Treatment

✍ Wierda, W. G. 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 60 KB

PCN88 AN ECONOMIC EVALUATION OF RITUXIMA

PCN88 AN ECONOMIC EVALUATION OF RITUXIMAB VERSUS OTHER FIRST-LINE TREATMENTS FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN POLAND

✍ P Kawalec; E Stawowczyk; M Russel-Szymczyk; M Szkultecka-Debek; R Aultman; E Car 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Novel agents and strategies for treatmen

Novel agents and strategies for treatment of p53-defective chronic lymphocytic leukemia

✍ Michael R. Grever; David M. Lucas; Amy J. Johnson; John C. Byrd 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Angiopoietin-2 plasma dosage predicts ti

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

✍ Maffei, R.; Martinelli, S.; Santachiara, R.; Rossi, D.; Guarnotta, C.; Sozzi, E. 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 347 KB